4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Luye Pharma Group Ltd. (2186) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Yantai, China with about 5,221 employees. Its market capitalization is roughly CNY 8 billion. In the fiscal year ended 2025-12-31, 2186 reported CNY 6.3B in revenue and CNY 619M in net income.
Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 6.3B | CNY 6.1B | CNY 6.1B | CNY 6.0B | — |
| Gross Profit | CNY 4.2B | CNY 4.0B | CNY 4.2B | CNY 4.1B | — |
| Operating Income (EBIT) | CNY 1.3B | CNY 1.3B | CNY 1.0B | CNY 954M | — |
| Net Income | CNY 619M | CNY 472M | CNY 533M | CNY 605M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 32.8B | CNY 29.6B | CNY 25.5B | CNY 24.2B | — |
| Total Liabilities | CNY 14.5B | CNY 13.9B | CNY 12.0B | CNY 13.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2186 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms